Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. FUCICORT CREAM [SIN00723P]

FUCICORT CREAM [SIN00723P]

Active ingredients: FUCICORT CREAM

Last updated 26 October 2025

Product Info

FUCICORT CREAM

[SIN00723P]

Product information

Active Ingredient and Strength

BETAMETHASONE VALERATE EQV BETAMETHASONE - 1 MG/G
FUSIDIC ACID - 20 MG/G

Dosage Form

CREAM

Manufacturer and Country

LEO PHARMA A/S - DENMARK
LEO LABORATORIES LIMITED - IRELAND

Registration Number

SIN00723P

Licence Holder

DKSH SINGAPORE PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

D07CC01

Indications
Fucicort® is indicated in inflammatory dermatoses where bacterial infection is present or likely to occur. Inflammatory dermatoses include atopic eczema, discoid eczema, stasis eczema, seborrhoeic, dermatitis, contact dermatitis, lichen simplex chronicus, psoriasis, discoid lupus erythematosus.

Dosage
Uncovered lesions: 2–3 daily applications.
Covered lesions: Less frequent application may be adequate.

Contra-indications
Hypersensitivity to fusidic acid/sodium fusidate, betamethasone valerate or to any of the Excipients.

Due to the content of corticosteroid, Fucicort® is contraindicated in the following conditions: Systemic fungal infections

Primary skin infections caused by fungi, virus or bacteria, either untreated or uncontrolled by appropriate treatment (see Special Warnings and Precautions for Use – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information)

Skin manifestations in relation to tuberculosis, either untreated or uncontrolled by appropriate therapy.

Perioral dermatitis and rosacea